Grünenthal Limited
TOR Building
St Cloud Way
Maidenhead SL6 8BN
Phone: +44 (0)870 351 8960

For Medical Information, Reporting Safety and Quality Related Issues see here

... About us

We are an independent, family-owned company with headquarters in Aachen, Germany. We are present in 29 countries with affiliates in Europe, Latin America and the USA. Our products are sold in more than 100 countries and we employ around 4,700 employees worldwide.

... Company Overview

Although firmly rooted in Germany, today we are very much a growing global business.

... History

At Grünenthal, conducting our business responsibly is a core part of our company’s strategy and culture. As a global leader in pain management, Grünenthal aspires to create a positive impact on society – in our core business and beyond. We are guided by integrity, transparency and the highest ethical standards.

... Responsibility

Although firmly rooted in Germany, today we’re very much a growing global business, represented in 27 countries and maintaining production sites in five.

... Global Capabilities

We are dedicated to creating a better future for our patients, so getting involved with diverse initiatives that support this goal is vital.

... Initiatives

... Requests for Funding

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs.

... Products

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Ationdo.

... Ationdo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Nebido.

... Nebido

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Palexia.

... Palexia

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Qutenza.

... Qutenza

We are dedicated to creating a better future for our patients, Read the package leaflet information to find out more about Ralvo.

... Ralvo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Tramacet.

... Tramacet

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Versatis.

... Versatis

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Vimovo .

... Vimovo

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zydol.

... Zydol

We are dedicated to creating a better future for our patients, read the package leaflet information to find out more about Zomig.

... Zomig

Patients’ needs are at the heart of everything we do; using our passion for science, we develop long-lasting solutions that directly address these needs. Read the package leaflet information to find out more about our products.

... Reporting Safety and Quality Related complaints

Declarations of Payment and Support

Payments and support provided by Grünenthal in the UK

Grünenthal Ltd. is a committed member of the Association of the British Pharmaceutical Industry (ABPI). As such we adhere to the requirements of the ABPI Code of Practice in the conduct of our business. As part of this commitment, we declare annually all payments made to UK healthcare professionals (HCPs) by the UK organisation and our affiliate companies overseas. In addition we provide transparency on our interactions with, and support of patient organisations, and any grants and donations we provide to institutes and organisations. The figures below do not currently include payments made to HCPs for research and development or market research when the participant is unknown to Grünenthal. Grünenthal does not support individual HCPs to attend third party scientific meetings and medical congresses.

Further information on the requirements of the ABPI Code of Practice and its enforcement can be accessed from the Prescription Medicines Code of Practice Authority’s website: www.pmcpa.org.uk. The ABPI have also produced a leaflet regarding the public declaration of payments made to HCPs which can be downloaded from the website.

As per the ABPI Code of Practice, all transfers of value to UK HCPs and HCOs (including those provided as grants or donations) made in 2015 and subsequent years are to be disclosed on a central ABPI portal. The portal can be accessed using this web address: www.disclosureuk.org.uk. The content will be updated by 1st July each year for data from the preceding year. Support provided to patient organisations and other organisations in our local community will continue to be disclosed below.

2022

Support of Patient Organisations & Grants and Donations

Recipient	Activity Supported	Type	Value (£)
ARMA (Arthritis & Musculoskeletal Alliance)	ARMA Associate membership	P.O	£5,000
ARMA (Arthritis & Musculoskeletal Alliance)	ARMA MSK Health Inequalities	P.O	£10,000
MacMillan Cancer Support	Speaker @ Change Pain	GAD	£2427,7

M-N/A-UK-04-23-0003 - April 2023